215 related articles for article (PubMed ID: 8555492)
1. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway.
Borger P; Kauffman HF; Postma DS; Vellenga E
Blood; 1996 Jan; 87(2):691-8. PubMed ID: 8555492
[TBL] [Abstract][Full Text] [Related]
2. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
Borger P; Kauffman HF; Vijgen JL; Postma DS; Vellenga E
Exp Hematol; 1996 Feb; 24(2):108-15. PubMed ID: 8641331
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal.
Borger P; Vellenga E; Gringhuis SI; Timmerman JA; Lummen C; Postma DS; Kauffman HF
J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):231-40. PubMed ID: 9500757
[TBL] [Abstract][Full Text] [Related]
4. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP sensitive signalling by the CD28 marker requires concomitant stimulation by the T-cell antigen receptor (TCR/CD3) complex.
Skålhegg BS; Rasmussen AM; Taskén K; Hansson V; Jahnsen T; Lea T
Scand J Immunol; 1994 Aug; 40(2):201-8. PubMed ID: 8047842
[TBL] [Abstract][Full Text] [Related]
6. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells.
Tokoyoda K; Tsujikawa K; Matsushita H; Ono Y; Hayashi T; Harada Y; Abe R; Kubo M; Yamamoto H
Int Immunol; 2004 May; 16(5):643-53. PubMed ID: 15096485
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
Rincón M; Tugores A; López-Rivas A; Silva A; Alonso M; De Landázuri MO; López-Botet M
Eur J Immunol; 1988 Nov; 18(11):1791-6. PubMed ID: 2849551
[TBL] [Abstract][Full Text] [Related]
9. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.
Kolenko V; Rayman P; Roy B; Cathcart MK; O'Shea J; Tubbs R; Rybicki L; Bukowski R; Finke J
Blood; 1999 Apr; 93(7):2308-18. PubMed ID: 10090941
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
12. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
[TBL] [Abstract][Full Text] [Related]
13. Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells.
Kanda N; Watanabe S
Biochem Pharmacol; 2001 Aug; 62(4):495-507. PubMed ID: 11448460
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandin E2 on Th0-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine production.
Watanabe S; Yssel H; Harada Y; Arai K
Int Immunol; 1994 Apr; 6(4):523-32. PubMed ID: 8018594
[TBL] [Abstract][Full Text] [Related]
15. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis.
Kanda N; Enomoto U; Watanabe S
J Invest Dermatol; 2001 Dec; 117(6):1635-46. PubMed ID: 11886533
[TBL] [Abstract][Full Text] [Related]
16. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
Zeng L; An S; Goetzl EJ
J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
[TBL] [Abstract][Full Text] [Related]
17. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.
June CH; Ledbetter JA; Gillespie MM; Lindsten T; Thompson CB
Mol Cell Biol; 1987 Dec; 7(12):4472-81. PubMed ID: 2830495
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
June CH; Ledbetter JA; Lindsten T; Thompson CB
J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
[TBL] [Abstract][Full Text] [Related]
19. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
Park YG; Kang SK; Noh SH; Park KK; Chang YC; Lee YC; Kim CH
Int Immunopharmacol; 2004 Jun; 4(6):779-89. PubMed ID: 15135319
[TBL] [Abstract][Full Text] [Related]
20. cAMP regulates IL-10 production by normal human T lymphocytes at multiple levels: a potential role for MEF2.
Liopeta K; Boubali S; Virgilio L; Thyphronitis G; Mavrothalassitis G; Dimitracopoulos G; Paliogianni F
Mol Immunol; 2009 Jan; 46(3):345-54. PubMed ID: 19058854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
